Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Aarntzen, Erik H. J. G."'
Autor:
Boudewijns S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Bloemendal M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Haas N; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Aarntzen EHJG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Lesterhuis WJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; School of Biomedical Sciences, University of Western Australia, Crawley, Australia., Gorris MAJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Croockewit A; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Woude LL; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., Welzen M; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., de Goede A; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands., Hato SV; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Punt CJA; Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Vries IJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl.; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Mar; Vol. 69 (3), pp. 477-488. Date of Electronic Publication: 2020 Jan 24.
Autor:
van Willigen WW; From the Department of Tumor Immunology and the Department of Medical Oncology., Gerritsen WR; Departments of Medical Oncology., Aarntzen EHJG; Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2019 Nov; Vol. 44 (11), pp. 905-906.
Autor:
Bloemendal M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., van Willigen WW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Werner JEM; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Aarntzen EHJG; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., de Groot JWB; Oncological Center Isala, Zwolle, The Netherlands., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., van der Hoeven JJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands. hans.dewilt@radboudumc.nl.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2019 Nov; Vol. 26 (12), pp. 3945-3952. Date of Electronic Publication: 2019 Mar 04.
Autor:
Boudewijns S; Departments of *Medical Oncology †Tumor Immunology ‡Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen §Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., Westdorp H, Koornstra RH, Aarntzen EH, Schreibelt G, Creemers JH, Punt CJ, Figdor CG, de Vries IJ, Gerritsen WR, Bol KF
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2016 Jul-Aug; Vol. 39 (6), pp. 241-8.
Autor:
Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Westdorp H; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Wimmers F; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Tel J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Winkels G; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Blokx WA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Welzen ME; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Mus RD; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Jacobs JF; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Kelderman S; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Blank CU; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. jolanda.devries@radboudumc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 May 01; Vol. 22 (9), pp. 2155-66. Date of Electronic Publication: 2015 Dec 28.
Autor:
Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands., Blokx WA; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands., Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Mus RD; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Graaf CA; Department of Pulmonary Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Centre, Amsterdam, The Netherlands., Adema GJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Gerty.Schreibelt@radboudumc.nl.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2016 Mar; Vol. 65 (3), pp. 327-39. Date of Electronic Publication: 2016 Feb 10.
Autor:
Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Mensink HW; Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, the Netherlands; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands., Keunen JE; Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, the Netherlands., Coulie PG; De Duve Institute, Université Catholique de Louvain, Brussels, Belgium., de Klein A; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands., Paridaens D; Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. Electronic address: J.deVries@ncmls.ru.nl.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2014 Nov; Vol. 158 (5), pp. 939-47. Date of Electronic Publication: 2014 Jul 17.
Autor:
Zelba H; Department of Internal Medicine II, Section for Transplantation Immunology and Immunohematology; Department of Immunology, University of Tübingen, Tübingen; henning.zelba@klinikum.uni-tuebingen.de., Weide B; Division of Dermatooncology, Department of Dermatology, University Medical Center;, Martens A; Department of Internal Medicine II, Section for Transplantation Immunology and Immunohematology;, Derhovanessian E; Department of Internal Medicine II, Section for Transplantation Immunology and Immunohematology;, Bailur JK; Department of Internal Medicine II, Section for Transplantation Immunology and Immunohematology;, Kyzirakos C; Department of Pediatric Oncology and Hematology, University Children's Hospital;, Pflugfelder A; Division of Dermatooncology, Department of Dermatology, University Medical Center;, Eigentler TK; Division of Dermatooncology, Department of Dermatology, University Medical Center;, Di Giacomo AM; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy;, Maio M; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy;, Aarntzen EH; Nijmegen Centre for Molecular Life Sciences (NCMLS); Department of Nuclear Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands; and., de Vries J; Nijmegen Centre for Molecular Life Sciences (NCMLS);, Sucker A; Department of Dermatology, University Medical Center, Essen, Germany;, Schadendorf D; Department of Dermatology, University Medical Center, Essen, Germany;, Büttner P; Skin Cancer Research Group, School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Australia., Garbe C; Division of Dermatooncology, Department of Dermatology, University Medical Center;, Pawelec G; Department of Internal Medicine II, Section for Transplantation Immunology and Immunohematology;
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Aug 15; Vol. 20 (16), pp. 4390-9. Date of Electronic Publication: 2014 Jun 17.
Autor:
Aarntzen EH; Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands., Srinivas M, Bonetto F, Cruz LJ, Verdijk P, Schreibelt G, van de Rakt M, Lesterhuis WJ, van Riel M, Punt CJ, Adema GJ, Heerschap A, Figdor CG, Oyen WJ, de Vries IJ
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Mar 15; Vol. 19 (6), pp. 1525-33. Date of Electronic Publication: 2013 Feb 04.
Autor:
Tel J; Department of Tumor Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands., Aarntzen EH, Baba T, Schreibelt G, Schulte BM, Benitez-Ribas D, Boerman OC, Croockewit S, Oyen WJ, van Rossum M, Winkels G, Coulie PG, Punt CJ, Figdor CG, de Vries IJ
Publikováno v:
Cancer research [Cancer Res] 2013 Feb 01; Vol. 73 (3), pp. 1063-75. Date of Electronic Publication: 2013 Jan 23.